Form 4: Aspira Women's Health Director Winfred Parnell Reports Stock Transactions

Director Winfred Parnell of Aspira Women's Health Inc. reports the vesting and conversion of restricted stock units into common stock on March 31, 2025.

Summary

• Winfred Parnell, a director of Aspira Women's Health Inc., reported a transaction involving restricted stock units (RSUs).
• On March 31, 2025, 5,156 RSUs vested and were converted into common stock.
• These RSUs were part of a grant of 20,625 RSUs awarded on August 22, 2024.
• Following the transaction, Parnell directly owns 66,053 shares of common stock and 5,156 RSUs.

Sentiment

Score: 5

Explanation: This is a routine disclosure of stock transactions by a company insider. It doesn't inherently indicate positive or negative sentiment, but rather reflects standard corporate governance practices.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their stock transactions. It doesn't necessarily reflect broader industry trends but offers insight into the actions of key personnel within Aspira Women's Health.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider activity.
• The vesting of RSUs may have a minor dilutive effect on existing shareholders.

Key Dates

Keywords

Aspira Women's Health, Director, Winfred Parnell, Stock Transaction, Restricted Stock Units, RSUs, Common Stock, Vesting, Form 4